VRDN

20.78

2.76% -0.59

Handel nachbörslich: 20.78

Viridian Therapeutics Inc (VRDN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$21.37

Offen:

$21.04

24-Stunden-Volumen:

874.37K

Relative Volume:

1.15

Marktkapitalisierung:

$1.70B

Einnahmen:

$305.00K

Nettoeinkommen (Verlust:

$-328.98M

KGV:

-5.4256

EPS:

-3.83

Netto-Cashflow:

$-309.60M

1W Leistung:

-1.05%

1M Leistung:

+10.12%

6M Leistung:

+56.24%

1J Leistung:

-11.72%

1-Tages-Spanne:

$20.71

$21.30

1-Wochen-Bereich:

$20.71

$22.36

52-Wochen-Spanne:

$9.90

$27.20

Viridian Therapeutics Inc Stock (VRDN) Company Profile

Firmenname

Viridian Therapeutics Inc

Sektor

Healthcare (1140)

Branche

Biotechnology (636)

Telefon

617.272.4600

Adresse

221 CRESCENT STREET, WALTHAM

Mitarbeiter

143

Twitter

Nächster Verdiensttermin

2024-11-11

Neueste SEC-Einreichungen

VRDN's Discussions on Twitter

Vergleichen Sie VRDN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VRDN Viridian Therapeutics Inc	20.78	1.75B	305.00K	-328.98M	-309.60M	-3.83
VRTX Vertex Pharmaceuticals Inc	412.22	104.45B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	469.36	60.95B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	572.60	59.11B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	812.95	49.23B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.94	35.92B	4.56B	-176.77M	225.30M	-1.7177

Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-25	Fortgesetzt	Jefferies	Buy
2024-12-19	Herabstufung	Wells Fargo	Overweight → Equal Weight
2024-11-25	Eingeleitet	TD Cowen	Buy
2024-09-11	Bestätigt	Needham	Buy
2024-06-11	Eingeleitet	Wolfe Research	Outperform
2024-06-06	Eingeleitet	Goldman	Buy
2024-05-09	Herabstufung	B. Riley Securities	Buy → Neutral
2024-05-09	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2023-06-14	Eingeleitet	BTIG Research	Buy
2023-06-14	Fortgesetzt	Credit Suisse	Outperform
2023-05-30	Eingeleitet	RBC Capital Mkts	Outperform
2023-04-17	Eingeleitet	Wells Fargo	Overweight
2023-03-30	Eingeleitet	Stifel	Buy
2022-12-19	Eingeleitet	Cowen	Outperform
2022-12-19	Eingeleitet	Needham	Buy
2022-12-16	Eingeleitet	Credit Suisse	Outperform
2022-12-01	Eingeleitet	H.C. Wainwright	Buy
2022-06-23	Eingeleitet	B. Riley Securities	Buy
2021-11-18	Eingeleitet	SVB Leerink	Outperform
2021-10-12	Eingeleitet	Evercore ISI	Outperform
2021-01-25	Eingeleitet	Ladenburg Thalmann	Buy

Alle ansehen

Viridian Therapeutics Inc Aktie (VRDN) Neueste Nachrichten

11:35 AM

Retinitis Pigmentosa Market to Expand Significantly by 2034, States DelveInsight Report | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc - The Globe and Mail

11:35 AM

03:54 AM

How buybacks impact Viridian Therapeutics Inc. stock valueWeekly Investment Recap & Smart Investment Allocation Tips - newser.com

03:54 AM

03:22 AM

Tools to monitor Viridian Therapeutics Inc. recovery probabilityEarnings Risk Report & High Return Stock Watch Alerts - newser.com

03:22 AM

03:08 AM

What machine learning models say about Viridian Therapeutics Inc.Quarterly Market Summary & Weekly Stock Breakout Alerts - newser.com

03:08 AM

Oct 13, 2025

Is Viridian Therapeutics Inc. stock reversal real or fakeJuly 2025 Action & Daily Volume Surge Signals - newser.com

Oct 13, 2025

Is this a good reentry point in Viridian Therapeutics Inc.2025 Volatility Report & Fast Entry High Yield Tips - newser.com

Oct 13, 2025

Using Ichimoku Cloud for Viridian Therapeutics Inc. technicals2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com

Oct 13, 2025

What candlestick patterns are forming on Viridian Therapeutics Inc.Forecast Cut & Free Technical Pattern Based Buy Signals - newser.com

Oct 13, 2025

Can machine learning forecast Viridian Therapeutics Inc. recoveryJuly 2025 Highlights & Low Risk Investment Opportunities - newser.com

Oct 13, 2025

Is Viridian Therapeutics Inc. building a consolidation baseMarket Trend Review & Weekly Momentum Stock Picks - newser.com

Oct 13, 2025

Is Viridian Therapeutics Inc. stock attractive for growth ETFsMarket Movement Recap & Fast Entry Momentum Alerts - newser.com

Oct 13, 2025

Oct 12, 2025

Why Viridian Therapeutics Inc. is moving todayWeekly Trade Recap & Scalable Portfolio Growth Methods - newser.com

Oct 12, 2025

Oct 11, 2025

Is Viridian Therapeutics Inc. (1S1) stock protected from inflationMarket Risk Report & Pattern Based Trade Signal System - newser.com

Oct 11, 2025

Viridian Therapeutics’ (VRDN) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World

Oct 11, 2025

Oct 10, 2025

Is Viridian Therapeutics Inc. stock safe for conservative investors2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com

Oct 10, 2025

Viridian Therapeutics supports key conferences with sponsorship initiative - Traders Union

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Viridian Therapeutics (NASDAQ:VRDN) - MarketBeat

Oct 09, 2025

How Viridian Therapeutics Inc. stock reacts to bond yieldsQuarterly Market Review & High Return Trade Opportunity Guides - newser.com

Oct 09, 2025

Oct 06, 2025

Real time alert setup for Viridian Therapeutics Inc. performanceBear Alert & Real-Time Volume Surge Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

Is Viridian Therapeutics Inc. stock dividend yield sustainable2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com

Oct 05, 2025

Will Viridian Therapeutics Inc. (1S1) stock beat growth indexesJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com

Oct 05, 2025

Oct 04, 2025